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Abstract
Exhausted CD8+ T cell responses during chronic viral infections are defined by a complex expression pattern of inhibitory
receptors. However, very little information is currently available about the coexpression patterns of these receptors on
human virus-specific CD8+ T cells and their correlation with antiviral functions, T cell differentiation and antigen recognition.
We addressed these important aspects in a cohort of 38 chronically HCV infected patients and found a coexpression of
inhibitory receptors such as 2B4, CD160 and KLRG1 in association with PD-1 in about half of the HCV-specific CD8+ T cell
responses. Importantly, this exhaustive phenotype was associated with low and intermediate levels of CD127 expression, an
impaired proliferative capacity, an intermediate T cell differentiation stage and absence of sequence variations within the
corresponding epitopes, indicating ongoing antigen triggering. In contrast, a low expression of inhibitory receptors by the
remaining HCV-specific CD8+ T cells occurred in concert with a CD127hi phenotype, an early T cell differentiation stage and
presence of viral sequence variations within the corresponding epitopes. In sum, these results suggest that T cell exhaustion
contributes to the failure of about half of HCV-specific CD8+ T cell responses and that it is determined by a complex
interplay of immunological (e.g. T cell differentiation) and virological (e.g. ongoing antigen triggering) factors.
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Introduction
Virus-specific CD8+ T cells play a central role in the outcome of
HCV infection. Indeed, several human and animal studies have
shown associations between strong and multispecific T cell
responses and viral clearance [1]. During chronic HCV infection,
viral escape and an impairment of HCV-specific CD8+ T cell
antiviral functions, e.g. the ability to proliferate or to secrete
antiviral cytokines such as interferon-c (IFN-c) contribute to virus-
specific CD8+ T cell failure. The underlying mechanisms for the
functional impairment of HCV-specific CD8+ T cells have not
been clarified in detail, although lack of CD4+ T cell help, action
of regulatory T cells and expression of immunomodulatory
cytokines, such as Il-10, have been suggested to contribute [1].
In addition, expression of the inhibitory receptor PD-1 has been
postulated to characterize a state of exhaustion of HCV-specific
CD8+ T cells in chronic HCV infection in analogy to murine
models of chronic viral infections [2]. Indeed, analysis of patients
with chronic HCV infection identified high levels of PD-1
expression on HCV-specific CD8+ T cells in blood and liver [3]
and blockade of PD-1 signaling resulted in the functional
restoration of blood-derived HCV-specific CD8+ T cell responses
in chronic infection [3,4]. However, the relevance of PD-1 in
defining exhausted HCV-specific CD8+ T cells has not been
unchallenged. For example, PD-1 blockade alone was unable to
restore the function of liver-derived HCV-specific CD8+ T cells
[5] while targeting additional inhibitory signaling pathways
reinvigorated the antiviral function [6]. In addition, PD-1
expression did not necessarily identify exhausted HCV-specific
CD8+ T cells during acute HCV infection in humans [7] and
chimpanzees [8]. Thus, PD-1 expression alone may not be
sufficient to determine exhaustion of HCV-specific CD8+ T cells
during HCV infection. In this context, it is interesting to note that
a recent study identified coexpression of additional inhibitory
receptors next to PD-1 as a critical determinant of CD8+ T cell
exhaustion in a murine model of chronic viral infection. For
example, expression of several inhibitory receptors including 2B4
and CD160 next to PD-1 was identified on strongly exhausted
virus-specific CD8+ T cells in severe LCMV infection [9]. 2B4 is a
coregulatory receptor of the SLAM-receptor family that is capable
of mediating both activatory and inhibitory signals upon ligand
CD48 binding [10]. High levels of 2B4 expression are associated
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CD160, a glycoylphosphatidylinositol-anchored receptor that
coinhibits T cells upon ligand HVEM binding [11], both highly
correlated in gene expression analysis with PD-1 expression [12].
The positive correlation with PD-1 expression was also observed
for other inhibitory receptors, such as LAG-3, a protein closely
related to CD4, and CTLA-4, a member of the CD28 family of
receptors [9]. Of note, expression of the inhibitory receptor Killer-
cell-lectin-like receptor G1 (KLRG1) showed no correlation with
exhaustion in severe LCMV infection [9]. KLRG1 mediates
proliferative dysfunction of differentiated CD8+ T cells upon
ligand E-cadherin binding [13,14,15] and its upregulation is
thought to be mediated by ongoing antigen triggering [16].
Despite these insights into inhibitory receptor expression on
CD8+ T cells, very little information is currently available about
the coexpression of these receptors on virus-specific CD8+ T cells
during chronic human infection such as HCV and their
association with T cell function, differentiation and antigen
recognition. Here, we show that the coexpression of inhibitory
receptors such as PD1, 2B4, CD160 and KLRG1 occurs in about
half of HCV-specific CD8+ T cell responses and that it is linked to
low or intermediate levels of CD127 expression, impaired
proliferative capacity, an intermediate T cell differentiation stage
and ongoing antigen-recognition. In contrast, the absence of
inhibitory receptor expression is associated with a CD127 high
phenotype and the presence of virus sequence variations in the
respective epitopes, indicating viral escape. These results indicate
that two different mechanisms contribute to the dysfunction of the
HCV-specific CD8+ T cell pool in chronic HCV infection. These
results also indicate that different factors are involved in the
development of HCV-specific CD8+ T cell exhaustion.
Results
Expression of inhibitory receptors on HCV-specific CD8+
T cells
In a first set of experiments, we screened HCV-specific CD8+ T
cells for the expression of a large set of inhibitory receptors such as
PD-1, 2B4, CD160, KLRG1, LAG-3 and CTLA-4 in a cohort of
10 chronically HCV infected patients. We compared the
expression of these receptors on HCV-specific CD8+ T cells with
the expression on FLU-specific CD8+ T cells that represent a
memory population. As shown in Fig. 1, we found an elevated
expression of PD-1, 2B4, CD160 and KLRG1 by HCV-specific
CD8+ T cells, however, no significant increase of LAG-3 and
CTLA-4 expression was observed. Based on these results, we
focused in the following on the analysis of the expression of PD-1,
2B4, CD160 and KLRG1 by HCV-specific CD8+ T cells in a
cohort of 38 patients with chronic HCV that displayed HCV-
specific tetramer responses (Table 1). As shown in Fig. 2A, we
found a high expression of PD-1 in our cohort (median: 88.9%).
Although PD-1 expression was high on most HCV-specific CD8+
T cell responses, it was not detectable on all HCV-specific CD8+
T cells (Fig. 2). 2B4 was expressed by some HCV-specific CD8+ T
cells with a median expression of 62.0% (Fig. 2A and B), whereas
CD160 was detectable only on a fraction of virus-specific CD8+ T
cells (median: 7.4%) (Fig. 2A and B). Expression of KLRG1 was
found to be quite variable, with a median expression of 40.8%
(Fig. 2A and B).
Expression of inhibitory receptors is associated with low
levels of CD127 expression on HCV specific CD8+ T cells
Previously, we have shown that HCV-specific CD8+ T cells
consist of subsets with distinct phenotypical and functional
properties that can be defined by CD127 expression [17]. Thus,
we asked whether the expression of CD127 is also linked to the
expression of the inhibitory receptors PD-1, 2B4, CD160 and
KLRG1 by HCV-specific CD8+ T cells. To address this question,
we costained the inhibitory receptors and CD127 on HCV-specific
CD8+ T cells. Depending on the expression level of CD127 (Fig.
S1), we defined three groups of HCV-specific CD8+ T cells as
displayed in Fig. 3A: a CD127 high (hi) group with more than
80% of epitope-specific CD8+ T cells expressing CD127, a
CD127 intermediate (mid) group with 50–80% of CD127
expression and a CD127 low (lo) group with less than 50%
expression of CD127. Importantly, we found a clear association
between the expression of CD127 and the expression of inhibitory
receptors on HCV-specific CD8+ T cells. Indeed, CD127lo cells
highly expressed PD-1 (median 97.5%), 2B4 (median 80.0%) and
CD160 (median 19.3%) (Fig. 3B). CD127mid cells expressed
slightly reduced levels of PD-1 (median 86.7%), 2B4 (median
66.4%) and CD160 (median 8.9%). In contrast, CD127hi cells
showed a significantly lower expression of PD-1 (median 48.3%),
2B4 (median 35.7%) and CD160 (median 3.3%) (Fig. 3B).
KLRG1 was also higher expressed on HCV-specific CD8+ T
cells with a CD127lo phenotype compared to a CD127mid and
CD127hi phenotype (67.1% vs 40.8% vs 25.0%) (Fig. 3B). In
contrast to PD-1, 2B4 and CD160, however, the range of KLRG1
expression varied more strongly between both groups. Next, we
analyzed the coexpression of inhibitory receptors on HCV-specific
CD8+ T cells in 10 patients at the single cell level in a multi-
inhibitory receptor staining (Fig. S2). As shown in Fig. 3C, a
CD127lo phenotype was associated with a high frequency of
HCV-specific CD8+ T cells coexpressing multiple inhibitory
receptors. The inhibitory receptor coexpression profile of
CD127mid HCV-specific CD8+ T cells was reduced compared
to CD127hi cells. For example, in our cohort, more than 80% of
CD127lo cells coexpressed 2 or more inhibitory receptors while
coexpression was found in less than 55% of CD127mid cells
(Fig. 3C). In contrast, a CD127hi phenotype was associated with
low or absent levels of inhibitory receptor coexpression. These
results clearly illustrate that the coexpression of multiple inhibitory
Author Summary
About 170 million people are infected with hepatitis C
virus (HCV), which may cause severe liver disease and liver
cancer. Upon acute infection, only about 30% of patients
are able to eliminate the virus spontaneously while about
70% of patients develop chronic infection. It is known that
a successful immune response against HCV depends on
virus-specific CD8+ T cells. However, during chronic
infection, these cells are impaired in their antiviral function.
In this study, we found that the exhaustion is characterized
by the expression of multiple inhibitory receptors, such as
PD-1, 2B4, CD160 and KLRG1. Of note, the coexpression of
these receptors depends on the ongoing recognition of
the viral antigen and the maturation stage of the T cell.
The remaining virus-specific T cell responses that are not
exhausted do not recognize the virus present in the
patients any more due to viral mutations, indicating viral
escape. Thus, they fail to exert antiviral activity, although
they share characteristics of fully functional memory T
cells. In sum, we have found that T cell exhaustion
contributes to the failure of about half of HCV-specific
CD8+ T cell responses and that it is determined by a
complex interplay of immunological and virological
factors. These findings will be important to consider in
the design of new antiviral vaccination strategies.
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CD127 expression.
Coexpression of inhibitory receptors on CD127lo
HCV-specific CD8+ T cells correlates with impaired
proliferative capacity
Next, we asked whether the coexpression of multiple inhibitory
receptors on CD127lo CD8+ T cells defines functionally impaired
HCV-specific CD8+ T cells, indicating exhaustion. We addressed
this by stimulating CD127lo, CD127mid and CD127hi HCV-
specific CD8+ T cells antigen-specifically for one week and by
analyzing the subsequent proliferation in the presence or absence
of PD-L1 blockade. Of note, we found significant differences
regarding the proliferative capacity and the effect of PD-L1
blockade between these groups (Fig. 4). Indeed, the proliferative
capacity of CD127hi HCV-specific CD8+ T cells was much
higher upon antigen stimulation compared to CD127mid and
CD127lo HCV-specific CD8+ T cells. As shown in Fig. 4A and
4E, CD127lo HCV-specific CD8+ T cells that expressed multiple
inhibitory receptors proliferated poorly upon antigen stimulation.
However, these cells could be reinvigorated partially upon
blockade of the inhibitory PD-1/PD-L1 signaling pathway,
indicating that they were in a functional reversible state of
exhaustion. CD127mid HCV-specific CD8+ T cells displayed an
improved proliferative capacity upon antigen stimulation (Fig. 4B).
In contrast to CD127lo and CD127mid cells, CD127hi HCV-
specific CD8+ T cells proliferated vigorously (Fig. 4C) upon
stimulation with peptide alone. Additional PD-L1 blockade
resulted in only a minor increase in proliferation. In a subsequent
analysis of 15 patients, we found that the increase in HCV-specific
CD8+ T cells due to PD-L1 blockade was about 2.2fold for
CD127lo cells. This increase was significantly higher compared to
CD127mid (1.5fold) and CD127hi cells (1.2fold) (p,0.01)
(Fig. 4D). These results indicate that CD127lo HCV-specific
CD8+ T cells are functionally impaired in vivo and are functionally
dependent on inhibitory receptor blockade, indicating exhaustion.
The expression of specific inhibitory receptors is linked to
stage of T cell differentiation
It has previously been shown that the expression of inhibitory
CD8+ T cell receptors, e.g. PD1 is linked to the stage of T cell
differentiation [18,19]. Thus, we asked whether the coexpression
of CD127 and all inhibitory receptors analyzed in our study was
linked to certain stages of T cell differentiation. For this analysis,
we assessed post-thymic human CD8+ T cell differentiation using
a linear model based on CD27, CCR7 and CD45RA expression
as displayed in Fig. 5A [18]. CD127 expression was highest in
naı ¨ve and early T cell subsets (subsets 1 and 2), but reduced in late
differentiated CD8+ T cells, indicating that CD127 expression was
linked to early stages of T cell differentiation (Fig. 5B). In
agreement with a previous study, the expression of PD-1 was
highest on intermediate differentiated CD8+ T cells (subset 3) and
lowest on naı ¨ve and late differentiated CD8+ T cells [19] (Fig. 5C).
Interestingly, the expression patterns of 2B4, CD160 and KLRG1
Figure 1. Expression of various inhibitory receptors by HCV-specific CD8+ T cells. The expression of PD-1, 2B4, CD160, KLRG1, CTLA-4 and
LAG-3 was monitored on HCV-specific CD8+ T cell responses targeting multiple immunodominant HCV epitopes of 10 consecutive patients and
compared to the expression of these receptors on virus-specific CD8+ T cells targeting an immunodominant Influenza matrix epitope. Mean
expression and SEM of each inhibitory receptor on virus-specific CD8+ T cells is shown.
doi:10.1371/journal.ppat.1000947.g001
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unique, individual profiles. 2B4 expression was lowest on naı ¨ve
CD8+ T cells but progressively increased along the differentiation
subsets reaching almost 100% expression on late-differentiated
CD8+ T cells (Fig. 5D). CD160 expression was lowest in naı ¨ve T
cells and increased in further differentiated subsets with two
expression peaks in intermediate subset 3 and late differentiated T
cell subset 5 (Fig. 5E) while KLRG1 showed a similar expression
pattern as 2B4 being low in naı ¨ve and early subsets but enriched in
late differentiated subsets (Fig. 5F). Overall, these results indicate
that inhibitory receptors are increasingly expressed by further
differentiated CD8+ T cells. However, since very distinct patterns
of expression were observed for each marker, the expression of one
inhibitory receptor does not necessarily indicate coexpression of
others. Thus, we asked whether coexpression of the inhibitory
receptors 2B4, CD160 and KLRG1 together with PD-1 occurred
in a specific T cell differentiation subset. Indeed, as shown in Fig. 6,
we identified the highest level of coexpression of all markers in the
intermediate T cell subset 3. These results indicate that inhibitory
receptors exhibit individual and distinct expression patterns linked
to T cell differentiation and that coexpression of 2B4, CD160 and
KLRG1 with PD-1 indicating exhaustion occurs in intermediate
rather than late differentiated CD8+ T cell subsets.
Finally, we asked whether the same association can also be
found within the HCV-specific CD8+ T cell population. As shown
in Fig. 7 and in agreement with previous findings, we observed
that HCV-specific CD8+ T cells consisted mostly of early and
intermediate differentiated T cells. Interestingly, the differentiation
of HCV-specific CD127hi, CD127mid and CD127lo cells was
significantly different (p,0.0001). The majority of CD127hi cells
belonged to the early differentiation subset 2, whereas CD127mid
cells were distributed at comparable levels in subset 2 and subset 3.
In contrast, HCV-specific CD127lo cells were prominently found
within the intermediate subset 3. Keeping in mind that the
coexpression of inhibitory receptors is highest in the intermediate
subset 3 and associated with a CD127lo phenotype, these results
clearly suggest that there is a complex link between CD127
expression, T cell differentiation and T cell exhaustion.
Expression of inhibitory receptors on CD127lo CD8+ T
cells is dependent on ongoing antigen recognition
In a final set of experiments, we set out to determine whether
the differential expression of inhibitory receptors by phenotypically
and functionally distinct HCV-specific CD8+ T cell populations is
related to the autologous viral sequence present in a given patient.
To address this issue, we sequenced the autologous viral sequences
of genotype 1 patients corresponding to recognized CD8+ T cell
epitopes (Table 2). Importantly, sequence variations from the
genotype consensus sequence were significantly more prevalent
within epitopes targeted by CD127hi HCV specific CD8+ T cells
with a low expression of inhibitory receptors (p,0,0001)(Fig. 8A).
We confirmed that these sequence variations represented viral
escape in several patients by stimulating HCV-specific CD8+ T
cells with peptides matched to both the autologous and consensus
sequence. Indeed, as shown for six representative patients in
Fig. 8B, HCV-specific CD8+ T cells produced high levels of IFN-c
upon stimulation with the consensus sequence peptide, but not
when stimulated with the variant autologous peptide. Further-
more, proliferation of these HCV-specific CD8+ T cells was
significantly reduced upon stimulation with the variant autologous
peptide, indicating viral escape (data not shown). These results
indicate that viral escape mutations are linked to a CD127hi
phenotype whereas a CD127mid or CD127lo phenotype is linked
to ongoing antigen recognition of the autologous virus sequence.
To further test this hypothesis, we analyzed HCV-specific CD8+ T
cells from patients with multiple immunodominant T cell
responses that harbored consensus and variant sequences in
different epitopes. Indeed, different expression profiles of inhibi-
tory receptors and CD127 could be observed within the same
patient depending on the virus sequence (patient 4, Fig. 8C,
Table 2). Indeed, although both immunodominant responses were
detectable at a comparable frequency (Fig. S3), all NS3-1406-
Table 1. Characteristics of the study population.
Patient Sex Age gt
viral load
(IU/ml)
ALT
(U/l)
Liver
histology
1 m 67 1b n.a. 90 u2/u2
2 f 70 1b 7208937 60 u2/u3–4
3 m 52 1b 1409300 85 n.a.
4 m 30 1a 81230 39 u1/u0
5 m 46 2b 400288 249 u2/u3
6 m 25 1a 729658 80 u1/u1
7 m 42 1a 4679963 235 u2/u3
8 f 65 5 1558856 65 u2/u2
9 f 54 1b 208729 45 u1/u2
10 m 53 3a 2096500 147 u2/u2
11 m 38 3a 438607 41 u2/u1
12 m 32 3a 7691548 515 u2–3/u2–3
13 f 40 1b 1400000 35 u1/u0
14 f 69 1b 297000 60 u1/u2
15 m 51 1a 1201680 98 u2/u2–3
16 f 44 1a 685910 62 n.a.
17 f 70 1a 1887862 219 u2/u2
18 f 63 1b 2568188 104 u1/u2
19 f 55 3a 819293 68 u3/u3
20 m 31 1a 791341 287 u1/u1
21 f 57 1b 3160130 101 u1/u3
22 f 25 1b 50658 112 u1/u0
23 f 67 1b 427220 34 u1/u2
24 f 30 1b 37499 54 u0/u0
25 m 58 1a 3802978 177 u1/u3
26 f 48 1a 363636 43 n.a.
27 m 28 1b 78947 33 u2/u1
28 m 40 1a 382481 163 u2/u1
29 m 54 1a 3185390 133 u2/u3
30 f 61 1b 1537679 184 u2/u1
31 f 55 1b 995000 40 u3/u1
32 f 43 1b 171803 34 u0/u0
33 f 56 1a 938114 91 u2/u1
34 m 36 1a 4999910 75 u1/u2
35 m 40 1a 4011231 43 u2/u2
36 m 41 1a 1360020 65 u3/u2
37 f 54 1b 297322 65 u1/u1
38 f 45 1a 1316760 25 u0/u1
Liver biopsies were rated for degree of inflammation/degree of fibrosis
according to the METAVIR score. Abb. f, female; gt, HCV genotype; m, male; n.a.,
not available.
doi:10.1371/journal.ppat.1000947.t001
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1 (14.3%), 2B4 (4.17%), CD160 (2.09%) and KLRG1 (25.0%),
whereas an opposite phenotype was observed on NS5-2594
specific CD8+ T cells, of which only 9,09% expressed CD127, but
high levels of PD-1 (86.7%), 2B4 (81.8%), CD160 (27.3%) and
KLRG1 (86.7%) (Fig. 8C, 8D). These results underline that the
mechanisms responsible for inhibitory receptor coexpression
operate in an epitope-specific manner depending on the
autologous virus sequence. To further test the hypothesis that
the low expression of inhibitory receptors and high expression of
CD127 are indeed caused by absence of antigen triggering in vivo,
we stimulated CD127hi HCV-specific CD8+ T cells with the
consensus peptide in vitro. Importantly, this peptide specific
stimulation induced a downregulation of CD127 and an
upregulation of inhibitory receptor expression after a seven day
culture (shown in Fig. 9). In sum, the downregulation of CD127
expression and upregulation of inhibitory receptors upon antigen
stimulation suggest that the absence of antigen triggering in vivo is
responsible for a CD127hi phenotype with a low expression of
inhibitory receptors. In agreement with this hypothesis, we found a
low expression of CD127 and a high expression of inhibitory
receptors by virus-specific CD8+ T cells that targeted epitopes
without sequence variations, indicating ongoing antigen recogni-
tion (Fig. 8A). These results also underscore the importance of
evaluating autologous viral sequences in studies aimed at
investigating the mechanisms of virus-specific CD8+ T cell failure.
Discussion
Here, we have investigated the expression of inhibitory
receptors by virus-specific CD8+ T cells during chronic HCV
infection and their association with CD127 expression, prolifer-
ative capacity, T cell differentiation and antigen recognition. We
found a specific pattern of expression of inhibitory receptors by
HCV-specific CD8+ T cells. Indeed, a large fraction of the HCV-
specific CD8+ T cell responses detectable in our cohort
coexpressed 2B4, CD160 and KLRG1 next to PD1. These results
are interesting in the light of a recent study by Blackburn et al.
demonstrating a clear association between a specific expression
pattern of inhibitory receptors including 2B4, CD160, LAG-3 and
CTLA-4 next to PD-1 and severe exhaustion of virus-specific
CD8+ T cells in LCMV infection in mice [9]. Interestingly, we did
not observe a significant expression of LAG-3 and CTLA-4 on
HCV-specific CD8+ T cells in our study. However, these results
are not surprising since it has previously been shown that CTLA-4
expression by HCV-specific CD8+ T cells is only detectable to
some degree in the liver, but not in the blood of chronically
infected patients [5]. In addition, a gene expression analysis of
Figure 2. Expression of PD-1, 2B4, CD160 and KLRG1 on HCV-specific CD8+ T cells. (A) Frequency of inhibitory receptor expression on
HCV-specific CD8+ T cells. Each dot represents inhibitory receptor expression on epitope-specific CD8+ T cells. Median expression of inhibitory
receptors in the study cohort was 88,9% (PD-1), 62,0% (2B4), 7,4% (CD160), and 40,8% (KLRG1). (B) Representative tetramer stainings chosen to depict
approximately the median inhibitory receptor expression of the total cohort. Plots are displayed using biexponential transformation (FlowJo 8.8.6).
doi:10.1371/journal.ppat.1000947.g002
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4 coexpression showed a weaker association with PD-1 compared
to 2B4 and CD160 coexpression [12]. Thus, these combined
results indicate a dynamic hierarchical pattern of inhibitory
receptor expression by exhausted CD8+ T cells with prominent
roles of 2B4 and CD160 [12]. Accordingly, our results indicate
that a significant fraction of HCV-specific CD8+ T cells display
typical markers of exhaustion. Importantly, HCV-specific CD8+ T
cell exhaustion defined as a loss of CD8+ T cell function, e.g.
proliferation and cytokine secretion has been reported by several
groups [4,5,20,21,22]. Our findings implicate that therapeutic
targeting of exhausted CD8+ T cells during chronic HCV
infection may require not only the blockade of one inhibitory
receptor pathway, but rather a cocktail of antibodies targeting
multiple inhibitory pathways [6]. In line with these findings, we
observed only a 2.2fold increase in proliferation of exhausted
CD127lo HCV-specific CD8+ T cells upon PD-1/PD-L1
blockade (Fig. 4D). An even smaller increase in proliferation due
to PD-1/PD-L1 blockade was seen in CD127hi HCV-specific
CD8+ T cells, however, this may be explained by the finding that
these cells proliferate vigorously in the absence of blockade,
indicating that they are not significantly inhibited (Fig. 4C–E and
[17]). Clearly, additional studies should address the effect of 2B4,
CD160 and KLRG1 receptor blockade on exhausted T cells as
soon as suitable blocking reagents are available.
2B4 is a coregulatory receptor capable of mediating activatory
and inhibitory signals in CD8+ T cells [23]. It was previously
considered as a predominantly activating receptor in humans [24].
However, a recent study addressed the dual roles of murine and
human 2B4 receptor signaling and found that both human and
murine 2B4 can exert both inhibitory or activatory receptor
functions [10]. Importantly, high levels of 2B4 surface expression
were linked to inhibitory 2B4 function, whereas low levels of 2B4
surface expression promoted activatory 2B4 signals [10]. Based on
the data analyzed in our study, we cannot exclude that ligation of
2B4 on HCV-specific CD8+ T cells may result in a costimulatory
Figure 3. Inhibitory receptor expression is inversely linked to level of CD127 expression. (A) Three groups of HCV-specific CD8+ T cell
responses can be distinguished by level of CD127 expression. High levels of CD127 expression (.80%) are displayed by black circles, intermediate
levels of CD127 (50–80%) by grey circles and a low expression of CD127 (,50%) by white circles. (B) Expression of inhibitory receptors PD-1, 2B4,
CD160 and KLRG1 is shown for CD127hi (black circles), CD127mid (grey circles) and CD127lo (white circles) HCV-specific CD8+ T cells. Significant
differences of inhibitory receptor expression between the CD127 subgroups were observed for PD-1 expression (p,0.0001), 2B4 expression
(p,0.0001), CD160 expression (p,0.05) and KLRG1 expression (p,0.0001). (C) Coexpression of inhibitory receptors on HCV-specific CD8+ T cells on a
single-cell-level. Displayed is the frequency of HCV-specific CD8+ T cells within a given epitope expressing 0 (white), 1 (light grey), 2 (grey), 3 (dark
grey) or 4 (black) inhibitory receptors. Representative diagrams are shown for a CD127hi epitope (pt. 4-NS3-1406), CD127mid epitope (pt. 26-NS3-
1406) and CD127lo epitope (pt. 4-NS5-2594). Coexpression of inhibitory receptors inversely correlates with CD127 expression.
doi:10.1371/journal.ppat.1000947.g003
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positivity only on cells with a high surface expression level of 2B4
(Fig. 2B and data not shown), indicating that 2B4 may act as an
inhibitory receptor on these cells. Further studies will be needed to
clarify whether 2B4 expression on virus-specific CD8+ T cells,
indeed, promotes inhibitory signals.
Of note, we observed significant levels of KLRG1 expression on
HCV-specific CD8+ T cells (Fig. 1,2). KLRG1 is up-regulated by
virus-specific CD8+ T cells upon repetitive antigenic stimulation
and frequently used as a marker for T cell differentiation [16,25].
Although KLRG1 expression was not shown to be strongly
associated with PD-1 coexpression by exhausted CD8+ T cells in
mice it was, however, identified on a significant fraction of
exhausted CD8+ T cells [9,12]. Since the up-regulation of
KLRG1 is induced by repetitive antigen stimulation, it is well
possible that KLRG1 expression might not directly reflect T cell
exhaustion but rather ongoing antigen recognition, that, however,
by itself is thought to be the prerequisite for the development of
CD8+ T cell exhaustion [26,27].
Our results also show that the expression level of the inhibitory
receptors PD-1, 2B4, CD160 and KLRG1 is linked to a specific
stage of cell differentiation. Recently, a linear model of human
CD8+ T cell differentiation has been developed that distinguishes
between naı ¨ve, early, intermediate and late differentiated cells
[28]. The differentiation status of CD8+ T cells is influenced by
the history of antigenic stimulation, clonal cell division, telomere
length and proliferative capacity of CD8+ T cells [18]. Here, we
found that the expression of PD-1 was highest on CD8+ T cells
with an intermediate T cell differentiation phenotype. In contrast,
2B4, CD160 and KLRG1 were differentially expressed by late
differentiated CD8+ T cells (Fig. 5). However, the highest level of
coexpression of all inhibitory receptors was observed within the
intermediate T cell differentiation stage (Fig. 6), indicating that
exhaustion of CD8+ T cells is most likely linked to this specific
subset. It remains unclear whether the coexpression of inhibitory
receptors 2B4, CD160 and KLRG1 by late differentiated cells in
the absence of PD-1 may also define a specific subset of exhausted
CD8+ T cells. However, this is rather unlikely since coexpression
Figure 4. Proliferative capacity and exhaustion inversely correlate with CD127 expression. Proliferation of HCV-specific CD8+ T cells
upon peptide stimulation in the presence or absence of PD-L1 blockade was measured by reduction in PBSE fluorescence in short term cultures of 15
patients. Representative stainings are shown for (A) CD127lo (pt.4-NS5-2594), (B) CD127mid (pt. 13-NS3-1073) and (C) CD127hi (pt. 32-NS5-2594) HCV-
specific CD8+ T cells. (D) Comparison of the increase in proliferation depending on PD-L1 blockade. Depicted are the mean values and SEM for the
ratio (frequency of HCV-specific CD8+ T cells after peptide stimulation and PD-L1 blockade/frequency of HCV-specific CD8+ T cells after peptide
stimulation). This ratio reflects the effect of PD-L1 blockade in addition to peptide stimulation. PD-L1 blockade in the cohort analyzed was
significantly more effective for peptide-stimulated CD127lo cells (mean 2.2) than for CD127mid (mean 1.5) and CD127hi cells (mean 1.2) (p,0.01). (E)
Proliferation index of peptide-stimulated HCV-specific CD8+ T cells in the presence (right side) and absence (left side) of PD-L1 blockade. The
proliferation index (PI) was calculated by the formula (frequency of HCV-specific CD8+ T cells after culture/frequency of HCV-specific CD8+ T cells ex
vivo) and reflects the proliferative capacity of the cell, which was highest for CD127hi HCV-specific CD8+ T cells compared to CD127mid and CD127lo
cells.
doi:10.1371/journal.ppat.1000947.g004
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T cells has been shown to define a functional cytotoxic CD8+ T
cell population [24,29].
Another important finding of our study is that coexpression of
inhibitory receptors on HCV-specific CD8+ T cells is linked to the
expression level of CD127. We have previously described the
existence of subsets of HCV-specific CD8+ T cells with distinct
functional properties that can be distinguished by the level of
CD127 expression [17]. Here, we classified HCV-specific CD8+ T
cells depending on the level of CD127 expression into three
groups: CD127lo, CD127mid and CD127hi cells. CD127lo HCV-
specific CD8+ T cells express markers associated with effector cells
and are dysfunctional in terms of proliferation whereas CD127hi
cells phenotypically and functionally resemble memory CD8+ T
cells [17]. These memory-like properties are also reflected by an
increased expression of antiapoptotic molecules [30,31](Fig. S3).
Here, we found that high coexpression of inhibitory receptors next
to PD-1 was restricted to CD127lo HCV-specific CD8+ T cells
with impaired proliferative capacity that could be reinvigorated
upon PD-1/PD-L1 signaling blockade, thus, correlating well with
the impaired functional state of these cells. We also found that
HCV-specific CD8+ T cells do not represent a homogenously
differentiated CD8+ T cell population. This novel finding was
made possible through the use of polychromatic flow cytometry
that allowed us to simultaneously stain HCV-specific CD8+ T cells
for the set of differentiation markers recommended by Appay et al.
[18] and extends previous reports regarding the differentiation of
HCV-specific CD8+ T cells that used conventional 4-color flow
cytometry [18,28]. Of note, the differentiation stage of HCV-
specific CD8+ T cells was significantly different for CD127hi,
CD127mid and CD127lo cells (Fig. 7). In addition, the
intermediate differentiation of HCV-specific CD8+ T cells
characterized by the coexpression of multiple inhibitory receptors
(as observed prominently for CD127lo cells) correlates with the
coexpression of inhibitory receptors in intermediate differentiation
subsets observed on the general CD8+ T cell population. Since
these results underline the existence of phenotypically and
functionally very different HCV-specific CD8+ T cell populations
during chronic HCV infection that can be defined by the
differential expression of CD127 and inhibitory receptors,
respectively, it will be important to distinguish between these
populations in future studies analyzing HCV-specific CD8+ T
cells.
Another important finding of our study is that the expression
of inhibitory receptors by virus-specific CD8+ Tc e l l si s
associated with ongoing antigen recognition and the absence of
v i r a le s c a p e .S i n c ew ec o u l dn o ta n a l y z et h ev i r u ss e q u e n c et h a t
initially infected our patients, and we thus could not observe the
development of escape mutations as has been elegantly shown in
recent longitudinal studies in acute HCV infection [32,33], we
assumed that the majority of patients was infected with the
genotype consensus sequence (table 2). This approach has some
limitations, for example it cannot be ruled out that remnants of a
prior infection with an alternate genotype or varying epitope
sequence confounded our analysis (for example, the sequence of
the autologous epitope matches the genotype consensus sequence
in one CD127hi patient (the NS3-1406 epitope in subject 9)). In
addition, it is impossible to dissect whether a variant epitope that
matches the heterologous genotype sequence that is targeted by a
CD127hi T cell response represents viral escape or whether the
T cell response represents the remnant of a prior resolved
infection with the alternate genotype (e.g., the NS5-2594 epitope
in subject 32). Clearly, these issues can only be addressed in
cohorts of HCV-infected patients, in which the sequence of the
inoculum and information about the T cell response prior to
infection is known. However, the clear association of high levels
of CD127 expression on virus-specific CD8+ T cells with the
presence of autologous sequence variations from the consensus
epitopes, the reduced IFN-c production and reduced prolifera-
tion of CD8+ T cells upon stimulation with variant but not with
Figure 5. Receptor expression profiles are linked to T cell
differentiation. (A) Schematic overview of the differentiation stage of
CD8+ T cells assessed by differential CD27, CCR7 and CD45RA
expression. (B–F) Expression of CD127 and inhibitory receptors PD-1,
2B4, CD160 and KLRG1 in individual CD8+ T cell differentiation subsets.
Each dot represents the frequency of CD127 or inhibitory receptor
expression on CD8+ T cells belonging to the given differentiation
subset of an individual patient.
doi:10.1371/journal.ppat.1000947.g005
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cases. Of note, we also found a clear association between the
expression level of inhibitory receptors next to PD1 and the
absence of sequence variations indicating ongoing antigen
recognition. These results are in agreement with recent studies
showing that high levels of specific antigen drive CD8+ T cell
exhaustion [27] and that exhaustion of CD8+ T cells can be
prevented by the emergence of viral escape mutations that
abrogate epitope recognition [34]. In line with these findings,
emergence of viral sequence variations was associated with a
Figure 6. Coexpression of 2B4, CD160 and KLRG1 with PD-1 is linked to an intermediate differentiation stage. Frequency of CD8+ T
cells coexpressing inhibitory receptors 2B4, CD160 and KLRG1 next to PD-1 is shown depending on the differentiation stage as defined in Fig. 5A.
Values were calculated by dividing the number of coexpressing CD8+ T cells belonging to the 5 differentiation subsets analyzed by the total number
of coexpressing CD8+ T cells. A total of 5 patients were analyzed.
doi:10.1371/journal.ppat.1000947.g006
Figure 7. Differences in HCV-specific CD8+ T cell differentiation depending on CD127 expression. The frequency of HCV-specific CD8+ T
cells identified in the differentiation subsets defined in Fig. 5A is depicted for CD127hi (Black circles), CD127mid (grey circles) and CD127lo (white
circles) responses. Significant differences between CD127 subgroups were observed for differentiation subset 2 (p,0.0001) and subset 3 (p,0.0001).
The majority of CD127hi responses was found in subset 2 (median 64,8%) while the majority of CD127lo cells was observed in subset 3 (median
68,1%). CD127mid cells were distributed at comparable levels in subset 2 (median 38,7%) and subset 3 (median 45,7%).
doi:10.1371/journal.ppat.1000947.g007
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expression in acute and chronic HCV infection [32,33] and
HIV infection [35]. It is also interesting to note that we observed
sequence variations in about half of the targeted T cell epitopes.
Although the number of HCV-specific CD8+ T cell epitopes
analyzed in our study was limited, and it is thus hard to make
firm conclusions about the general frequencies of viral escape
among HCV-specific CD8+ T cell epitopes, our results are in
agreement with recent studies that also have shown the presence
of viral escape mutations in about 50% of targeted CD8+ Tc e l l
epitopes [36,37]. Thus, both mechanisms of CD8+ Tc e l lf a i l u r e ,
viral escape and T cell exhaustion, defined by the coexpression
of multiple inhibitory receptors, seem to contribute significantly
to the ineffective viral control and they can be easily identified by
specific surface expression patterns.
In sum, our results show that the coexpression of inhibitory
receptors by exhausted HCV-specific CD8+ T cells is linked to
CD127 expression, proliferative capacity, the stage of T cell
differentiation and ongoing antigen recognition. Thus, a complex
interplay of immunological and virological factors determines T
cell exhaustion in human chronic viral infection. These findings
have also important implications for the rational design of
immunotherapeutic treatment strategies in chronic HCV infection
since only exhausted CD8+ T cells still recognize the present viral
antigens and should thus be targeted by immunomodulatory
strategies.
Table 2. Epitope sequence analysis and correlation with CD127 expression.
Pt gt NS3-1073 % CD127 NS3-1406 % CD127 NS5-2594 % CD127 NS5-2841 % CD127
1 1b CVNGVCWTV 0.06 lo
2 1b CVNGVCWTV 0.01 lo
3 1b n.a. 0.07 lo
4 1a KLVALGVNAV 0.02 hi ALYDVVSKL 0.03 lo
6 1a CINGVCWSI 0.02 lo
7 1a CINGVCWTA 0.01 hi
9 1b KLSGLGLNAV 0.17 hi
13 1b n.a. 0.03 mid
14 1b CVNGVCWTV 0.02 lo
15 1a CINGVCWTV 0.12 lo
16 1a CINGVCWTV 0.05 lo ALYDVVSKL 0.03 lo
17 1a n.a. 0.02 lo n.a. 0.02 lo
18 1b CINGVCWTV 0.01 lo
20 1a CINGVCWTV 0.01 mid
21 1b CINGVCWTV 0.02 mid
22 1b CLNGVCWTV 0.10 mid
23 1b CVNGVCWTV 0.02 lo
24 1b VRMILATHF 0.18 hi
25 1a CINGVCWSV 0.03 hi
26 1a CINGVCWTV 0.03 lo KLVALGVNAV 0.04 mid
27 1b VRMIMMTHF 0.16 hi
28 1a CINGVCWTV 0.04 lo
29 1a CINGVCWTV 0.27 lo
30 1b CVNGVCWTV 0.10 lo
31 1b CVSGVCWTV 0.13 hi
32 1b CINGVCWTV 0.01 mid KLVGLGLNAV 0.02 hi ALYDVVSKL 0.20 hi
33 1a CINGVCWTA 0.05 hi KLVALGINAV 0.07 mid ALYDVVSKL 0.06 lo
34 1a CINGVCWTV 0.02 mid
35 1a CINGVCWTV 0.12 lo
36 1a CINGVCWTV 0.01 mid
37 1b CVNGVCWTV 0.03 lo
38 1a CINGVCWTV 0.03 lo
Con 1a CINGVCWTV KLVALGINAV ALYDVVSKL ARMILMTHF
Con 1b CVNGVCWTV KLSGLGLNAV ALYDVVSTL ARMILMTHF
Autologous virus sequences were obtained from patients with genotype 1 with detectable HCV-specific CD8+ T cell responses targeting immunodominant epitopes.
Level of CD127 on T cells recognizing these epitopes is indicated next to the tetramer frequency and the respective sequence (hi: .80% CD127 expression, mid: 50–
80% CD127 expression, lo: ,50% CD127 expression). The consensus sequences for genotype 1a and 1b are shown below. Differing amino acids from variant autologous
sequences are highlighted in bold. Abb.: Con, consensus sequence; gt, HCV genotype; n.a., not available; Pt, patient.
doi:10.1371/journal.ppat.1000947.t002
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PLoS Pathogens | www.plospathogens.org 10 June 2010 | Volume 6 | Issue 6 | e1000947Figure 8. Inhibitory receptor expression is linked to recognition of viral antigen. (A) CD127 expression of HCV-specific CD8+ T cells
grouped depending on the autologous virus sequence. Cross-recognition was defined as sequence variation from consensus that has been
previously shown to be cross-recognized [39]. (B) PBMC of patients with variant autologous sequences (see table 2) were stimulated for IFN-c
expression after short term culture with different concentrations of consensus peptide (black line) or variant autologous peptide (dashed line).
Representative diagrams are shown for pts. 4, 24–27 and 32. Frequency of IFN-c expression is shown on the y axis, peptide concentration (mM) on the
x axis. Viral escape is indicated by the strongly reduced IFN-c production after stimulation with the autologous peptide sequence. (C) Divergent
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Study group
38 patients with chronic HCV infection presenting at the
outpatient hepatology clinic of the University Hospital Freiburg with
detectable HCV-specific CD8+ tetramer responses were included in
the study after obtaining written informed consent from the patients
and approval by the ethics committee of the Albert-Ludwigs-
Universita ¨t, Freiburg. All investigations have been conducted
according to the principles expressed in the Declaration of Helsinki.
The characteristics of the study population are included in table 1.
HCV viral load and sequencing
Detection of HCV viral load and epitope sequencing was
performed as previously described [37].
Lymphocyte isolation
Lymphocytes were analyzed from patient blood as previously
described [17].
Peptides and tetramers
Peptides corresponding to immunodominant HLA-A2- and
HLA-B27- epitopes (sequences CINGVCWTV, KLVALGINAV,
ALYDVVTKL, ARMILMTHF) and variant autologous patient
sequences were obtained from Biosynthan, Berlin, Germany.
These peptides were dissolved in 100% dimethyl sulfoxide (Sigma-
Aldrich, Germany) at 20 mg/ml and further diluted to 1 mg/ml
with RPMI 1640 (Gibco) before use. HLA-A2- and HLA-B27-
tetramers were obtained from the National Tetramer Core Facility
at Emory University, Atlanta. Influenza-specific pentamers
containing the immunodominant GILGFVFTL peptide were
purchased from ProImmune, Oxford, UK.
Antibodies
The following reagents were used for polychromatic stainings:
anti-2B4-FITC, anti-CD27-APC-eFluor780, anti-CD45RA-
PerCP-Cy5.5, anti-PD-1-PE, anti-CD127-APC Alexa Fluor 750,
anti-CD127-APC-eFluor 780, anti-CD127-Pacific Blue, anti-IgM-
PerCPeFluor710, streptavidin-eFluorV450 (Ebioscience), anti-Bcl-
2-PE, anti-CCR7-PE-Cy7, anti-CD28-FITC, anti-CD38-PE, anti-
CD8-APC H7, anti-CD8 AmCyan (BD Biosciences), anti-CD127-
PE, anti-CD160-PE, anti-CD57-FITC (Beckman Coulter), anti-
CTLA-4-FITC (R&D), anti-CD3-PerCP, anti-CD160-FITC, pu-
rified anti-CD160 (BioLegend), anti-LAG-3-Atto488 (Alexxis),
anti-LAG-3 FITC (LifeSpan BioSciences), anti-LAG-3-PE
(R&D). Viaprobe (7-AAD, BD Biosciences) was used for dead
cell exclusion. The anti-KLRG1-AlexaFluor488 and anti-
KLRG1-biotin antibodies were generated as previously described
[16].
Polychromatic flow cytometry
Tetramer and antibody staining was performed as previously
described [17]. For the multi-inhibitory receptor staining, the cells
were first stained with the CD160-IgM-pure antibody, then with
the anti-IgM-PerCP secondary antibody, then stained with the
KLRG1-biotin antibody followed with the streptavidin-
eFluorV450 antibody. Cells were then incubated with the tetramer
followed by the staining with the fluorophore-conjugated antibod-
ies (CD8-AmCyan, 2B4-FITC, PD-1-PE, CD127-APC-
eFluor780). Incubation time was 15 min for each staining step
and cells were washed twice in between the addition of staining
reagents.
Samples were acquired on a FACS Canto II flow cytometer (BD
Biosciences) and analyzed with FlowJo v8.8.6 software (TreeStar
Inc.). Gates for positivity in polychromatic panels were determined
by fluorescence-minus-one control stains, as recommended [38].
Proliferation and blockade assays
2*10‘6 freshly isolated PBMCs were labelled with 40 mM
Pacific Blue succinimidyl ester (PBSE, Invitrogen), and stimulated
with 10 mM peptide in the presence of 20 IU/ml rhIl-2 (Roche) in
1 ml complete medium (RPMI 1640 containing 10% fetal calf
serum, 1% streptomycin/penicillin, and 1.5% Hepes buffer
1 mol/L). Cells were incubated at 37uC in the presence or
absence of 10 mg/ml anti-PD-L1 (Ebioscience) for one week,
subsequently stained and analyzed by polychromatic flow
cytometry. PD-L1 blockade-dependent gain of proliferation was
determined by the ratio: frequency of HCV-specific CD8+ T cells
after peptide stimulation and PD-L1 blockade divided by the
frequency after peptide stimulation alone. The proliferation index
was calculated by dividing the frequency of HCV-specific CD8+ T
cells after stimulation by the frequency ex vivo.
CD127 expression by HCV-specific CD8+ T cells on two epitopes from a single individual (pt. 4) targeting the NS3-1406 and NS5-2594 epitopes. (D)
Overlay histograms of PD-1, 2B4, CD160 and KLRG1 expression on NS3-1406-specific CD8+ T cells (CD127hi) and NS5-2594-specific CD8+ T cells
(CD127lo) from patient 4.
doi:10.1371/journal.ppat.1000947.g008
Figure 9. Upregulation of inhibitory receptor expression on CD127hi cells upon antigen stimulation. Comparison of CD127, PD-1, 2B4,
CD160 and KLRG1 expression on HCV-specific CD8+ T cells prior and 7 days post stimulation are shown by overlay histograms for representative
patient 24 (total n=14).
doi:10.1371/journal.ppat.1000947.g009
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Statistical analysis was performed using GraphPad Prism 5
software (GraphPad Prism Software, Inc.). The statistical tests used
were ANOVA 1way analysis of variance followed by Newman-
Keuls Multiple Comparison Test (Fig. 3,4,7), and Mann-Whitney
U test (Fig. 8).
Supporting Information
Figure S1 Gating strategy for the assessment of CD127
frequencies. Virus-specific CD8+ T cells were determined by
tetramer staining and thresholds for CD127 positivity defined by
FMO controls. Representative pseudocolor plots are shown for (A)
CD127hi HCV-specific CD8+ T cells (pt. 4-NS3-1406) and (B)
CD127lo HCV-specific CD8+ T cells (pt. 4-NS5-2594).
Found at: doi:10.1371/journal.ppat.1000947.s001 (0.43 MB TIF)
Figure S2 Multi-inhibitory receptor analysis of HCV-specific
CD8+ T cells. The co-expression of PD-1, 2B4, CD160 and
KLRG1 on CD8+tetramer+ T cells was determined as follows: A)
The tetramer+ HCV-specific CD8+ T cell population was gated
on CD8+ T cells in the lymphocyte gate. Gates for CD127 and
inhibitory receptor expression were determined on the total CD8+
population in comparison to FMO controls. B) These gates were
applied to the tetramer+ population and a Boolean matrix used to
determine the number of inhibitory receptors expressed by
individual HCV-specific CD8+ T cells.
Found at: doi:10.1371/journal.ppat.1000947.s002 (0.80 MB TIF)
Figure S3 Analysis of Bcl-2 expression. In a total of 8 patients,
Bcl-2 expression on HCV-specific CD8+ T cells was analyzedA-
nalysis of Bcl-2 expression. In a total of 8 patients, Bcl-2 expression
on HCV-specific CD8+ T cells was analyzed after cell permea-
biliztion. Original data plots from patient 4 are shown and the
MFI of tetramer-positive cells is displayed. Bcl-2 expression
correlated with the level of CD127 expression. The coexpression
of inhibitory receptors of the displayed HCV-specific CD8+ T cells
is shown in Fig. 3C. after cell permeabiliztion. Original data plots
from patient 4 are shown and the MFI of tetramer-positive cells is
displayed. Bcl-2 expression correlated with the level of CD127
expression. The coexpression of inhibitory receptors of the
displayed HCV-specific CD8+ T cells is shown in Fig. 3C.
Found at: doi:10.1371/journal.ppat.1000947.s003 (0.29 MB TIF)
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